E
Kezar Life Sciences, Inc. KZR
$3.96 $0.000.00% NASDAQ
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

06/30/2025 03/31/2025 12/31/2024 09/30/2024 06/30/2024
Net Income -70.79M -78.63M -83.74M -95.78M -98.57M
Total Depreciation and Amortization 1.01M 1.03M 1.04M 1.06M 1.08M
Total Amortization of Deferred Charges 331.00K 354.00K 259.00K 252.00K 246.00K
Total Other Non-Cash Items 8.28M 9.70M 9.53M 11.72M 14.63M
Change in Net Operating Assets -3.14M -986.00K -1.30M 6.38M 3.53M
Cash from Operations -64.30M -68.54M -74.21M -76.37M -79.08M
Capital Expenditure -37.00K -37.00K -29.00K -19.00K -137.00K
Sale of Property, Plant, and Equipment -- -- -- 0.00 5.00K
Cash Acquisitions -- -- -- -- --
Divestitures -- -- -- -- --
Other Investing Activities 72.98M 73.80M 80.46M 84.58M 79.21M
Cash from Investing 72.94M 73.76M 80.43M 84.56M 79.08M
Total Debt Issued -- -- -- -- --
Total Debt Repaid -2.61M -1.30M -- -- --
Issuance of Common Stock 82.00K 103.00K 103.00K 115.00K 158.00K
Repurchase of Common Stock -- -- -- -- --
Issuance of Preferred Stock -- -- -- -- --
Repurchase of Preferred Stock -- -- -- -- --
Total Dividends Paid -- -- -- -- --
Other Financing Activities -- -- -- -- --
Cash from Financing -2.53M -1.20M 103.00K 115.00K 158.00K
Foreign Exchange rate Adjustments -22.00K -51.00K -63.00K 50.00K 11.00K
Miscellaneous Cash Flow Adjustments -- -- -- -- --
Net Change in Cash 6.09M 3.97M 6.26M 8.36M 167.00K